Allergy Immunotherapy Market Research Report - Global Forecast till 2027

Allergy Immunotherapy Market Research Report: Information, by Allergy Type (Allergic Rhinitis, Allergic Asthma, Peanut Allergy, Cat Allergy and others), Treatment (Sublingual Immunotherapy, Subcutaneous Immunotherapy (SCIT) and Specific Immunotherapy (SIT)) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/0988-CR | August 2019 | Region: Global | 88 Pages         

1 Report Prologue

2 Market Introduction

2.1 Introduction 18

2.2 Scope of Study 18

2.3 Research Objective 19

2.4 Assumptions & Limitations 19

2.4.1 Assumptions 19

2.4.2 Limitations 19

2.5 Market Structure 20

3 Research Methodology

3.1 Research Process 21

3.2 Primary Research 22

3.3 Secondary Research 22

3.4 Market Size Estimation 22

3.5 Forecast Model 24

4 Market Dynamics

4.1 Introduction 25

4.2 Drivers 25

4.2.1 Launch of New sublingual Immunotherapies in emerging Economies will Drive the Growth of the Market 25

4.2.2 Major Players are introducing Several Allergen Immunotherapy Tablets (AITs) in Potential Markets 26

4.2.3 Increase in risk Factors Causing Allergies 26

4.2.4 Rising Screening for Allergy and reimbursement Scenario 26

4.3 Restraint 27

4.3.1 Restricted Healthcare Spending in underserved Market of Europe will Restrain the Growth 27

4.4 Opportunity 27

4.4.1 Allergy Immune Therapies will be Launched in the US. 27

4.5 Challenges 28

4.5.1 High Cost of Allergy Immunotherapy 28

4.6 Micro Economic Indicators 28

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 30

5.1.1 Bargaining Power of Suppliers 31

5.1.2 Bargaining Power of Buyers 31

5.1.3 Threat of New Entrants 31

5.1.4 Threat of Substitutes 31

5.1.5 Intensity of Rivalry 31

5.2 Supply Chain Analysis 32

5.2.1 R&D 32

5.2.2 Parts Manufacturing 33

5.2.3 Distribution 33

5.2.4 Marketing & Sales 33

5.2.5 Post-Sales Monitoring 33

5.3 Pricing Analysis 33

5.4 Investment Opportunity Analysis 34

5.5 Merger and Acquisition Landscape 35

6 Allergy Immunotherapy Market, by Type of Therapy

6.1 Subcutaneous Immunotherapy (SCIT) 37

6.2 Sublingual Immunotherapy (SLIT) 38

7 Allergy Immunotherapy Market, by Types Of Allergies

7.1 Rhinitis 40

7.2 Asthma 40

7.3 Eye Allergy 41

7.4 Skin Allergy 41

8 Allergy Immunotherapy Market, by End User

8.1 Hospitals 43

8.2 Clinics 43

8.3 Diagnostic Centers 44

9 Global Allergy immunotherapy Market, by Region

9.1 Americas 46

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.1 North America 48

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.1.1 US 51

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.1.2 Canada 53

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2 Latin America 55

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.1 Brazil 57

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.2 Mexico 59

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.3 Argentina 61

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.4 Columbia 63

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.5 Chile 64

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.2.6 Rest of Latin America 66

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3 South America 67

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.1 Bolivia 70

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.2 Ecuador 73

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.3 Peru 75

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.4 Venezuela 77

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.1.3.5 Uruguay 78

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2 Europe 80

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1 Western Europe 82

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.1 Germany 84

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.2 France 86

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.3 UK 88

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.4 Italy 90

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.5 Spain 92

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.6 Russia 94

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.1.7 Rest of Western Europe 96

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.2 Central Europe 97

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.2.1 Switzerland 99

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.2.2 Slovenia 101

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.3 Eastern Europe 103

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.4 Greece 105

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.2.5 Rest of Eastern Europe 107

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3 Asia-Pacific 109

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.1 Japan 111

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.2 China 113

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.3 India 115

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.4 South Korea 117

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.5 Australia 118

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.3.6 New Zealand 120

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.4 Middle East & Africa 121

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.5 Middle East 124

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

9.6 Africa 125

Allergy Immunotherapy Market, by Type of Therapy

Allergy Immunotherapy Market, by Types Of Allergies

Allergy Immunotherapy Market, by End User

10 Company Landscape

10.1 Introductions 127

11 Company Profile

11.1 ALK Abello A/S 129

11.1.1 Overview 129

11.1.2 Product/Business Overview 129

11.1.3 Financial Overview 129

11.1.4 Key Development 131

11.1.5 SWOT Analysis 131

11.2 Allergy Therapeutics 132

11.2.1 Company Overview 132

11.2.2 Product/Business Segment Overview 132

11.2.3 Financial Overview 132

11.2.4 Key Development 133

11.2.5 SWOT Analysis 134

11.3 Circassia 135

11.3.1 Company Overview 135

11.3.2 Product/Business Segment Overview 135

11.3.3 Financial Overview 135

11.3.4 Key Development 136

11.3.5 SWOT Analysis 137

11.4 DBV Technologies 138

11.4.1 Company Overview 138

11.4.2 Product/Business Segment Overview 138

11.4.3 Financial Overview 138

11.4.4 Key Development 139

11.4.5 SWOT Analysis 139

11.5 Stallergenes Greer 140

11.5.1 Company Overview 140

11.5.2 Product/Business Segment Overview 140

11.5.3 Financial Overview 140

11.5.4 Key Development 142

11.5.5 SWOT Analysis 142

11.6 Merck KGaA (Allergopharma) 143

11.6.1 Company Overview 143

11.6.2 Product/Business Segment Overview 143

11.6.3 Financial Overview 144

11.6.4 Key Development 145

11.6.5 SWOT Analysis 145

11.7 HAL Allergy Group 146

11.7.1 Company Overview 146

11.7.2 Product/Business Segment Overview 146

11.7.3 Financial Overview 146

11.7.4 Key Development 146

11.7.5 SWOT Analysis 147

12 Conclusion

12.1 Key Findings 148

12.1.1 From CEO’s View Point 148

12.2 Key Companies To Watch 148

13 Appendix

13.1 Discussion Blue Print 149

14 List of Tables

TABLE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USDMILLION 2020–2027 36

TABLE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY (SCIT) USDMILLION 2020–2027 37

TABLE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBLINGUAL IMMUNOTHERAPY USDMILLION 2020–2027 38

TABLE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPES OF ALLERGIES USD MILLION 2020–2027 39

TABLE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR RHINITIS USD MILLION 2020–2027 40

TABLE 6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR ASTHMA USD MILLION 2020–2027 40

TABLE 7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR EYE ALLERGY USD MILLION 2020–2027 41

TABLE 8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SKIN ALLERGY USD MILLION 2020–2027 41

TABLE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 42

TABLE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR HOSPITALS USD MILLION 2020–2027 43

TABLE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR CLINICS USD MILLION 2020–2027 43

TABLE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR DIAGNOSTIC CENTERS USD MILLION 2020–2027 44

TABLE 13 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 45

TABLE 14 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 46

TABLE 15 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 47

TABLE 16 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 47

TABLE 17 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 48

TABLE 18 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 48

TABLE 19 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 49

TABLE 20 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 50

TABLE 21 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 50

TABLE 22 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 51

TABLE 23 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 51

TABLE 24 US ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 53

TABLE 25 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 53

TABLE 26 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 54

TABLE 27 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 54

TABLE 28 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 55

TABLE 29 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 56

TABLE 30 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 56

TABLE 31 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 57

TABLE 32 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 57

TABLE 33 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 58

TABLE 34 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 58

TABLE 35 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 59

TABLE 36 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 59

TABLE 37 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 61

TABLE 38 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 61

TABLE 39 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 62

TABLE 40 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 62

TABLE 41 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 63

TABLE 42 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 63

TABLE 43 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 64

TABLE 44 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 64

TABLE 45 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 65

TABLE 46 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 65

TABLE 47 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 66

TABLE 48 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 66

TABLE 49 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 67

TABLE 50 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 67

TABLE 51 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 68

TABLE 52 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 69

TABLE 53 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 69

TABLE 54 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 70

TABLE 55 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 70

TABLE 56 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 72

TABLE 57 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 73

TABLE 58 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 73

TABLE 59 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 75

TABLE 60 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 75

TABLE 61 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 76

TABLE 62 PERU ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 76

TABLE 63 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 77

TABLE 64 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 77

TABLE 65 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 78

TABLE 66 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 78

TABLE 67 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 79

TABLE 68 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 79

TABLE 69 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 80

TABLE 70 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 81

TABLE 71 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 81

TABLE 72 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 82

TABLE 73 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 82

TABLE 74 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 83

TABLE 75 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 84

TABLE 76 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 84

TABLE 77 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 85

TABLE 78 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 85

TABLE 79 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 86

TABLE 80 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 86

TABLE 81 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 87

TABLE 82 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 87

TABLE 83 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 88

TABLE 84 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 88

TABLE 85 UK ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 90

TABLE 86 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 90

TABLE 87 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 91

TABLE 88 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 91

TABLE 89 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 92

TABLE 90 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 92

TABLE 91 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 94

TABLE 92 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 94

TABLE 93 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 95

TABLE 94 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 95

TABLE 95 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 96

TABLE 96 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 96

TABLE 97 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 97

TABLE 98 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2020–2027 97

TABLE 99 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 98

TABLE 100 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 99

TABLE 101 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 99

TABLE 102 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 100

TABLE 103 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 100

TABLE 104 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 100

TABLE 105 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 101

TABLE 106 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 102

TABLE 107 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 102

TABLE 108 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2020–2027 103

TABLE 109 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 103

TABLE 110 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 104

TABLE 111 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 104

TABLE 112 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 105

TABLE 113 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 105

TABLE 114 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 107

TABLE 115 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 107

TABLE 116 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 108

TABLE 117 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 108

TABLE 118 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 109

TABLE 119 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 110

TABLE 120 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 110

TABLE 121 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 111

TABLE 122 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 111

TABLE 123 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 112

TABLE 124 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 112

TABLE 125 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 113

TABLE 126 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 113

TABLE 127 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 115

TABLE 128 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 115

TABLE 129 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 116

TABLE 130 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 116

TABLE 131 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 117

TABLE 132 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 117

TABLE 133 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 118

TABLE 134 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 118

TABLE 135 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 119

TABLE 136 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 119

TABLE 137 REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 120

TABLE 138 NEW ZEALAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 120

TABLE 139 NEW ZEALAND PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 121

TABLE 140 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 121

TABLE 141 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 122

TABLE 142 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 123

TABLE 143 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 123

TABLE 144 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 124

TABLE 145 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 124

TABLE 146 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 125

TABLE 147 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 125

TABLE 148 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 126

TABLE 149 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 126

TABLE 150 ALK-ABELLΓ“ A/S: KEY DEVELOPMENT 131

TABLE 151 ALLERGY THERAPEUTICS : KEY DEVELOPMENT 133

TABLE 152 CIRCASSIA : KEY DEVELOPMENT 136

TABLE 153 DBV TECHNOLOGIES: KEY DEVELOPMENT 139

TABLE 154 STALLERGENES GREER: KEY DEVELOPMENT 142

TABLE 155 MERCK KGAA: KEY DEVELOPMENT 145

TABLE 156 HAL ALLERGY GROUP: KEY DEVELOPMENT 146

15 List of Figures

FIGURE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY, 2020 (%) 15

FIGURE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY, 2020 (%) 16

FIGURE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS, 2020 (%) 16

FIGURE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION, 2020 (%) 17

FIGURE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: MARKET STRUCTURE 20

FIGURE 6 RESEARCH PROCESS 21

FIGURE 7 PORTERS FIVE FORCES MODEL 30

FIGURE 8 SUPPLY CHAIN: ALLERGY IMMUNOTHERAPY 32

FIGURE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USD MILLION 2020 & 2027 36

FIGURE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGIES USD MILLION 2020 & 2027 39

FIGURE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020 & 2027 42

FIGURE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020 & 2027 45

FIGURE 13 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION MARKET SHARE 2020 (%) 46

FIGURE 14 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 49

FIGURE 15 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 55

FIGURE 16 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY MARKET SHARE 2020 (%) 68

FIGURE 17 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020 & 2027 80

FIGURE 18 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 83

FIGURE 19 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS MARKET SHARE 2020 (%) 98

FIGURE 20 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USDMILLION 2020 & 2027 109

FIGURE 21 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020 & 2027 122

FIGURE 22 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 127

FIGURE 23 AMERICAS ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128

FIGURE 24 EUROPE ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128

FIGURE 25 ALK-ABELLΓ“ A/S: RECENT FINANCIAL 129

FIGURE 26 ALK-ABELLΓ“ A/S: BUSINESS REVENUE MIX (2015) 129

FIGURE 27 ALK-ABELLΓ“ A/S: GEOGRAPHIC REVENUE MIX 130

FIGURE 28 ALK-ABELLΓ“ A/S: SWOT ANALYSIS 131

FIGURE 29 ALLERGY THERAPEUTICS : RECENT FINANCIAL 132

FIGURE 30 ALLERGY THERAPEUTICS : GEOGRAPHIC REVENUE MIX 133

FIGURE 31 ALLERGY THERAPEUTICS : SWOT ANALYSIS 134

FIGURE 32 CIRCASSIA : RECENT FINANCIAL 135

FIGURE 33 CIRCASSIA : GEOGRAPHIC REVENUE MIX 136

FIGURE 34 CIRCASSIA : SWOT ANALYSIS 137

FIGURE 35 DBV TECHNOLOGIES: RECENT FINANCIAL 138

FIGURE 36 DBV TECHNOLOGIES: SWOT ANALYSIS 139

FIGURE 37 STALLERGENES GREER: RECENT FINANCIAL 140

FIGURE 38 STALLERGENES GREER: BUSINESS REVENUE MIX (2015) 140

FIGURE 39 STALLERGENES GREER: GEOGRAPHIC REVENUE MIX 141

FIGURE 40 STALLERGENES GREER: SWOT ANALYSIS 142

FIGURE 41 MERCK KGAA: RECENT FINANCIAL 144

FIGURE 42 MERCK KGAA: GEOGRAPHIC REVENUE MIX 144

FIGURE 43 MERCK KGAA: SWOT ANALYSIS 145

FIGURE 44 HAL ALLERGY GROUP: SWOT ANALYSIS 147

Allergy Immunotherapy Market

The Allergy Immunotherapy Market will obtain a CAGR of 10.85 % and a strong valuation of USD 4,324.7 million in the forecasted period from 2020 to 2027.

Segmentation

By Allergy Type Allergic Rhinitis Allergic Asthma Peanut Allergy Cat Allergy Others
By Treatment Sublingual Immunotherapy Subcutaneous Immunotherapy Specific Immunotherapy

Key Players

  • ALK Abello (U.K.)
  • Allergy Therapeutics (U.K.)
  • Circassia (U.K.)
  • DVB Technologies (U.K.)
  • HAL Allergy Group (U.K.)
  • Merck KGaA Allergopharma (U.K.)
  • Stallergenes Greer (U.K.)

Drivers

  • Increasing ailments of allergic rhinitis/conjunctivitis
  • Allergic asthma
Speak to Analyst Request a Free Sample

Allergy Immunotherapy Market Overview


The Allergy Immunotherapy Market will obtain a CAGR of 10.85 % and a strong valuation of USD 4,324.7 million in the forecasted period from 2020 to 2027. Allergic immunotherapy treats allergic asthma, allergic rhinitis/conjunctivitis, and severe insect susceptibility. It also includes daily doses of sublingual immunotherapy, a newly launched immunotherapy in various economies, and the presence of industrial players that will drive the market’s growth. Increasing demand for various medicines to treat illness is driving the market growth. To meet demand, companies are working on the research part to develop the medicines they need in the market. In addition, more and more anti-allergic tablets are being produced by the major players on the market.


The allergy immunotherapy market is in the global market as consumers' disposable incomes increase, and they can spend more on allergy-related treatments, which is an opportunity for growth in the allergy immunotherapy market during the forecast period. It's growing tremendously. In addition, increased environmental pollution increased alcohol consumption, and changes in diet and lifestyle have increased skin-related allergies and increased demand for allergic immunotherapy in the global market.


COVID-19 Analysis:

The covid -19 pandemics have hit our business industries and life on a different level. To cope up with this new normal, we have to make the widely analyzed strategies, and there is the need to focus on the cost-effective measures and high production of the products. Analysts are working upon the various reports of other industrial vehicles of how they tackled this disruption, and experts are researching upon these reports to give apt market insights to their clients. Also, because of the lockdown period and post lockdown period, many manufacturing units of the allergy immunotherapy market were shut down, which results in a steep downfall of the revenues along with decreased profit margin.

 
However, it is expected that the allergy immunotherapy market in the global market will recover from this global pandemic situation by the end of the second quarter and the beginning of the third quarter in the coming year during the forecasted period from 2020 to 2027.

Market Dynamics:

Drivers

The increasing demand for various drugs to treat ailments is adding growth to the market. To cope with the need, the companies are working upon the research part to develop the needed drugs in the market; in addition to this, more and more allergic ailment tablets have been produced by the key market players.
 
Opportunities

The allergy immunotherapy market is growing tremendously in the global market owing to an increase in personal disposable income of the consumers which enables them to spend more for the allergy-related treatments which act as an opportunity for the growth of the allergy immunotherapy market during the forecasted period. Moreover, increasing levels of pollution, increasing consumption of alcohol, and changing eating habits and lifestyles resulted in more skin-related allergies and hence increased demand for allergy immunotherapy market in the global market.

 
Restraints

The allergy immunotherapy market is increasing at an alarming rate in the global market but some factors hamper the growth of the allergy immunotherapy market like the side-effects such as skin-related disorders, gastrointestinal and respiratory disorders associated with the treatment hinders the growth of the allergy immunotherapy market in the global market. Another factor that restricts the growth of the allergy immunotherapy market in the global market is the high cost of treatment which is not afforded by everyone.

Value Chain Analysis

Both the supply and the demand for these tablets are increasing in the market, especially with the increasing kidney ailment diseases. With the advancement in technology, skin-related allergies can be cured in every nook and corner of the world as competitive players have established various units for testing and treatment of allergy immunotherapy market in the global market during the forecasted period from 2017 to 2023.

Segment Overview:

The allergy immunotherapy market in the global market has been divided based on the Allergy into various segments:
 
Allergic rhinitis- is the harmless substances that cause an allergic reaction.
 
Rhinitis, allergic asthma- it is the condition of sinus, ear condition, and trouble sleeping.
 
Peanut allergy-  it is the allergy to consuming peanuts. It happens when peanuts are considered a harmful substance in the body.

The allergy immunotherapy market in the global market has been divided based on the treatment into various segments:

Sublingual immunotherapy-  it is the treatment in which the doses are given in the smaller quantity, which increases the tolerance level of doses and the symptom of allergy is reduced.
 
Subcutaneous immunotherapy (SCIT)-  in this type, the administration of doses gradually increases to which the individual has allergic symptoms.
 
Specific immunotherapy (SIT)-  is the treatment used in dogs and cats; in this type, doses are administered to extract the allergen and reduce the infection in the body.
 
Regional Analysis -

Based on the report, the allergy immunotherapy market in the global market has been divided based on the region into Europe region,  American region, and the Middle East and the Africa regions, and the rest of the world.

 

  • The increased ailments of the chronic diseases in the Europe area is the fueling factor of the growth in the market of the European region which makes it the largest shareholding region of the market.

  • The high prevalence of allergic rhinitis & skin allergy makes the American region the second largest contributor to the allergy immunotherapy market.

  • The increasing sector of infrastructure and health facilities in allergic treatments makes Europe the fasted growing economy of the Allergy Immunotherapy Market.

  • The ailments of nasal allergies are the fueling factor of growth in the middle east Asia region. 


Competitive Landscape:
 
The most prominent market key players in the global market are as follows:

  • ALK Abello (U.K.)

  • Allergy Therapeutics (U.K.)

  • Circassia (U.K.)

  • DVB Technologies (U.K.)

  • HAL Allergy Group (U.K.)

  • Merck KGaA Allergopharma (U.K.)

  • Stallergenes Greer (U.K.)


These are the most prominent efficient key players in allergy immunotherapy in the global market and use various strategies to increase their customer base in the global market and make their policies for capturing the foreign market. Also, they do collaboration, mergers, and acquisitions and partnerships to expand their production base in different countries during the forecasted period from 2017 to 2023.
 
Recent Developments

In June 2022


Intrommune Therapeutics, Inc., a New York-based clinical biotechnology company developing a patient-friendly treatment platform for peanuts and other food allergies, is in the process of INT 301 for adult patients with peanut allergies. Announced amendments to Phase 1 OMEGA clinical trials. This change will extend the patient's study period to 48 weeks and include a maintenance phase. This maintenance period enables safety evaluation after long-term use of INT301.


In June 2022


QHSLab, Inc is a leading physician licensing and management company today focused on providing physicians with tools to leverage proactive, value-based healthcare solutions through new Point of Care technology. Announcing a strategic alliance with Medical License Factory, LLC. AllergiEnd® Digital Health Services for Allergen Diagnosis and Allergen Immunotherapy Products and Clinical Decision Support.


Report Overview:

The global allergy immunotherapy market research report consists of the following aspects:

  • Market Overview

  • COVID 19 Analysis

  • Market Segmentation

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Developments


With the increasing ailments of allergic rhinitis/conjunctivitis, allergic asthma, peanuts allergy, cat allergy, and stinging insect hypersensitivity, and the growing need for astringent tablets, the market is drastically growing to cope with the upsurging demands of the doses. 

As we saw, everything has two sides to the coin. If we talk about the Europe region, they considered it an underserved market, and investing in this will be an effort gone in vain, but with the proper research and development, the market will reach the estimated level.  The eminent key players in the market are also contributing the great shares and grabbing the opportunity related to the upsurging demand of the market size.

 
Users
 
Pharmaceutical companies, contract research manufacturing organizations, research, and development organizations, academic institutes, and many others.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 4,324.7 Million
  CAGR   10.85%
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2028
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Allergy Type, Treatment And Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   ALK Abello (UK), Allergy Therapeutic (UK), Circassia (UK), DVB Technologies (UK), (UK), and HAL Allergy Group (UK), Merck KGaA (Allergopharma), Stallergenes Greer (UK)
  Key Market Opportunities   newly launched immunotherapies
  Key Market Drivers

  • Increasing ailments of allergic rhinitis/conjunctivitis
  • Allergic asthma


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Allergy Immunotherapy Market is projected to grow at a 10.85%CAGR between 2020-2027.

    Notable players profiled in the Allergy Immunotherapy Market include HAL Allergy Group (UK), Merck KGaA (Allergopharma) (UK), Stallergenes Greer (UK), DBV Technologies (UK), Circassia (UK), Allergy Therapeutic (UK), and ALK Abello A/S (UK).

    Europe is predicted to spearhead the Allergy Immunotherapy Market.

    Allergy Immunotherapy Market is predicted to touch USD 4,324.7 million by 2027.

    Restricted healthcare spending may deter market growth.